Location History:
- N. Billerica, MA (US) (2010 - 2011)
- Bedford, MA (US) (2012)
- Bethlehem, PA (US) (2019 - 2024)
Company Filing History:
Years Active: 2010-2025
Title: Innovations of Jianxing Huang in Cognitive Impairment Treatment
Introduction
Jianxing Huang is a notable inventor based in Bethlehem, PA (US), recognized for his contributions to the field of cognitive impairment treatment. With a total of 11 patents, Huang has made significant strides in developing therapeutic solutions for various central nervous system (CNS) disorders.
Latest Patents
Huang's latest patents focus on benzodiazepine derivatives, compositions, and methods for treating cognitive impairment. These inventions relate to the use of α5-containing GABAreceptor agonists, which are designed to treat cognitive impairment associated with CNS disorders. His work addresses a range of conditions, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD), and various mental health disorders. The innovative approaches he has developed aim to improve the quality of life for individuals suffering from these debilitating conditions.
Career Highlights
Throughout his career, Huang has worked with several companies, including Agenebio, Inc. and Agennix USA Inc. His experience in these organizations has contributed to his expertise in the field of cognitive health and therapeutic development.
Collaborations
Huang has collaborated with notable colleagues such as Belew Mekonnen and John Anthony Butera. These partnerships have further enhanced his research and innovation capabilities, leading to advancements in treatment methodologies.
Conclusion
Jianxing Huang's work in the realm of cognitive impairment treatment showcases his dedication to improving therapeutic options for individuals affected by CNS disorders. His innovative patents and collaborations highlight the importance of continued research in this critical area of health.